Lenvatinib mesylate is under clinical development by Eisai and currently in Phase III for Gastric Cancer. According to GlobalData, Phase III drugs for Gastric Cancer have a 46% phase transition ...

Exlinkibart is under clinical development by Lyvgen Biopharma and currently in Phase I for Acral Lentiginous Melanoma.

LOS ANGELES—Noah Hudnut’s family had already spent $150,000 on his psychiatric care when he was hauled in handcuffs by police to the emergency room of UCLA medical center. On top of the ...

The differentiation in response rates between the acral and mucosal melanoma subtypes underscores the need for further stratified analyses to optimize treatment strategies. Future studies with larger ...

In fact, people of color are at risk of a certain type of cancer called acral lentiginous melanoma, which is not directly caused by ultraviolet (UV) radiation exposure. (It was the type that killed ...

“Below Deck Down Under” star Jason Chambers has been diagnosed with melanoma. The 52-year-old reality star publicly revealed his health news in an Instagram video on Monday. “Update on the ...

Acral melanoma, a skin cancer, forms on the palms, soles of feet, or under fingernails or toenails. It is not believed to be caused by sun exposure.

Overall, at 3-year follow-up, the benefit observed with nivolumab plus relatlimab compared with nivolumab in patients with advanced melanoma was sustained ... the trial for at least 100 days after ...